Ranbaxy opts out of Merck’s Generics business bidding
March 20th, 2007
A leading business media says that Ranbaxy opts out of Merck’s Generics business bidding. Ranbaxy is last Indian company in the race to pull out of the race. It is believed that the reason for opting out of the race, as per the media channel, is that the valuations have stretched a bit. Earlier Dr. Reddy’s opted to come out of the bidding.
Ranbaxy Laboratories Ltd opened at 318.90 and is currently trading at 324.00 (+2.22%)
Entry Filed under: Equities, Buzzing News, Pharmaceuticals
Leave a Comment
Some HTML allowed:
<a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <code> <em> <i> <strike> <strong>